Assignee
NEXYS THERAPEUTICS INC
US·3 granted patents·2 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
5 records- 0179US12168646B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Dec 17, 2024·0 cites·21 claims
- 0278US12371408B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·20 claims
- 0374US2026022099A1Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0469US2024398776A1Inhibitors of tgf-beta r1 (alk5) useful to treat cell proliferation disordersNEXYS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0552US12102626B2(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancerNEXYS THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2024·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →